{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T18:58:52Z","timestamp":1700074732965},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.dld.2005.07.008","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T07:11:29Z","timestamp":1128582689000},"page":"352-354","source":"Crossref","is-referenced-by-count":6,"title":["Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis"],"prefix":"10.1016","volume":"38","author":[{"given":"M.","family":"Pompili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pizzolante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Covino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Rapaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2005.07.008_bib1","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2005.07.008_bib2","first-page":"3","article-title":"A perspective on the clinical effectiveness and tolerance of interferon alpha","volume":"25","author":"Borden","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.dld.2005.07.008_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","article-title":"Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors","volume":"115","author":"Ronnblom","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2005.07.008_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/sarh.2002.37277","article-title":"Autoimmune disease complicating antiviral therapy for hepatitis C virus infection","volume":"32","author":"Leslie","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.dld.2005.07.008_bib5","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(89)90157-8","article-title":"Induction of hyperthyroidism by interferon alpha-2b","volume":"1","author":"Schultz","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2005.07.008_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon and retinopathy","volume":"11","author":"Guyer","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.dld.2005.07.008_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.99.3.557","article-title":"Cardiotoxicity of interferon. A review of 44 cases","volume":"99","author":"Sonnenblick","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.dld.2005.07.008_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2005.07.008_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2169\/internalmedicine.32.327","article-title":"Exacerbation of ulcerative colitis during alpha-interferon therapy for hepatitis C","volume":"32","author":"Mitoro","year":"1993","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2005.07.008_bib10","first-page":"269","article-title":"Ulcerative colitis in hairy cell leukemia. A case report","volume":"82","author":"Pecorari","year":"1991","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.dld.2005.07.008_bib11","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1097-0142(19911001)68:7<1538::AID-CNCR2820680714>3.0.CO;2-2","article-title":"Colonic ischemia complicating immunotherapy with interleukin-2 and interferon","volume":"68","author":"Sparano","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2005.07.008_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/BF02355061","article-title":"Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C","volume":"31","author":"Tada","year":"1996","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2005.07.008_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2005.07.008_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"19","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2005.07.008_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"Pegylated interferon alfa 2b and ribavirin treatment in patients with hepatitis C virus related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.dld.2005.07.008_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2005.07.008_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.dld.2005.07.008_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2005.07.008_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0002-9343(92)90792-A","article-title":"Digital vasculitis associated with interferon therapy","volume":"92","author":"Reid","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2005.07.008_bib20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1017\/S0022215100142197","article-title":"Sudden hearing loss in a patient hepatitis C virus positive on therapy with alpha-interferon: a possible autoimmune microvascular pathogenesis","volume":"112","author":"Cadoni","year":"1998","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.dld.2005.07.008_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1572-0241.2004.30372.x","article-title":"Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon\/ribavirin","volume":"99","author":"Forman","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2005.07.008_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002281-200201000-00006","article-title":"Cryoglobulinemia vasculitis","volume":"14","author":"Cacoub","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.dld.2005.07.008_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","article-title":"Sustained exacerbation of cryoglobulinemia-related vasculitis following treatment of hepatitis C with peginterferon alpha","volume":"16","author":"Batisse","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2005.07.008_bib24","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.92.10.4562","article-title":"Interferons alpha and beta down regulate the expression of basic fibroblast growth factor in human carcinomas","volume":"92","author":"Singh","year":"1995","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580500321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580500321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T19:20:56Z","timestamp":1548098456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086580500321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S159086580500321X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2005.07.008","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}